
结论很明确:这个市场不值得进入,已经是明显的超饱和价格战区。 新品牌新发布产品盈利率为0%,整体新发布产品盈利率也是0%,而且近几个月仍有新品牌不断进场,说明竞争没有缓和,反而在持续挤压利润。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很明确:这个市场不值得进入,你当前 50 万人民币预算也只能勉强覆盖单个ASIN的前期试水,但回报环境太差,属于低利润、强价格战市场。 现有数据里,市场可识别的盈利产品只占 4.55%,新品盈利率是 0%,而且新品牌新品盈利率也是 0%;这不是正常竞争,而是几乎没有新进入者能跑通的局面。
预算上看,Datdifen 的新ASIN B0G38GZ3LC 价格 9.44 美元,当前利润率只有 3.05%;另一个新ASIN B0H1XCL317 虽然标价 17.38 美元,利润率也只有 7.18%,都低于你应该接受的 15% 安全线。 老品牌 JNIHEEP 的 B0F3DDSB8Z、B0D7QGTPGR 也分别是 -1.14% 和 -5.29%,说明连成熟品牌都在亏;Afcabakila 的 B0GFDB9QWC 更是只有 0.22% 利润率,几乎没有可操作空间。更关键的是,市场里新品牌已出现 Datdifen、Afcabakila、Gouisalin、Ziopetru、Rostationa、KGCGJVB、Otoolling 等多个新进入者,结合低盈利率与大量失败样本,已经是明显的饱和和价格战信号。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不适合进入,结论很明确:已经进入价格战区,而且新品牌几乎没有成功样本。 目前样本里新品牌共7个、老品牌6个,但新上架产品12个里,盈利率是0%,整体新上架利润区间只有-6.34%到7.04%,明显低于你要求的15%可接受线,属于高风险、低回报市场。
这个市场不适合进入,已经是明显的价格战区,而且新品牌几乎没有真实成功样本。 当前样本里新产品利润分布非常差:新产品中 41.67% 落在 0%~10% 利润,25% 甚至是 -10%~0%,没有任何新产品达到 20% 以上利润;按市场口径看,整体已是高难度、低利润环境,不应该继续投入。
证据很直接:新品牌入场几乎全军覆没。 新品牌新发布产品的盈利率为 0%,非盈利率为 100%;这不是个别失手,而是整个新品牌组都没有跑出可复制的正向结果。样本里能看见的新品牌如 Datdifen、Afcabakila、Gouisalin、Ziopetru、Rostationa、KGCGJVB、Otoolling,几乎都在 2025-2026 年集中入场,但利润表现要么接近 0%,要么直接亏损。Afcabakila 的新品 B0GFDB9QWC 只有 0.22% 利润,几乎等于白忙;Datdifen 的 B0G38GZ3LC 虽然有 700 单、月销约 660,800,但利润也只有 3.05%;而 Datdifen 的另一个新品 B0H1XCL317 利润 7.18%,仍低于你要求的可接受线 15%。反过来,老品牌 JNIHEEP 的两条主力 ASIN B0D7QGTPGR、B0F3DDSB8Z 都是亏损(-5.29%、-1.14%),说明这个类目不是“换个品牌就能赢”,而是被成本和竞争一起压扁了。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0FDQC12Z5 | XuYelora | 2025-06-19 | Yes | $14.47 | 50pcs | $723.5 | 11.48% | $83.06 |
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
![]() | B0FW4H4263 | VeyFolzin.st | 2025-10-14 | No | $17.28 | 50pcs | $864.0 | 5.09% | $43.98 |
![]() | B0G38GZ3LC | Datdifen | 2025-11-21 | No | $9.44 | 700pcs | $6608.0 | 3.05% | $201.55 |
![]() | B0GFDB9QWC | Afcabakila | 2026-01-07 | No | $16.31 | -pcs | $- | 0.22% | $- |
![]() | B0GG1J6FGJ | Rostationa | 2026-01-10 | No | $15.99 | -pcs | $- | 13.44% | $- |
![]() | B0GFDYWXDB | Rostationa | 2026-01-11 | No | $9.99 | -pcs | $- | -5.69% | $- |
![]() | B0FPFN4ZRZ | Otoolling | 2025-09-02 | No | $13.99 | -pcs | $- | -5.15% | $- |
![]() | B0FMXSTX47 | Gouisalin | 2025-08-19 | No | $14.75 | -pcs | $- | 1.27% | $- |
![]() | B0FLXKV3DF | KGCGJVB | 2025-08-11 | No | $7.49 | -pcs | $- | -7.7% | $- |
![]() | B0H1XCL317 | Datdifen | 2026-05-15 | No | $17.38 | -pcs | $- | 7.18% | $- |
![]() | B0FMXYMTS9 | Gouisalin | 2025-08-19 | No | $- | -pcs | $- | -% | $- |
![]() | B0GG7J2DDQ | Rostationa | 2026-01-11 | No | $- | -pcs | $- | -% | $- |
![]() | B0FKMRBH26 | Ziopetru | 2025-07-31 | No | $- | -pcs | $- | -% | $- |
这个市场不适合进入,已经是明显的价格战/高竞争市场。 新品牌这次样本里 11/11 个新发布产品全部不盈利,整体新发布样本也是 12/12 全部不盈利;同时老品牌新发布也没有跑出盈利案例,说明不是“谁来都能做”的增长市场,而是“进来就很难赚”的挤压市场。
What is the ratio of profitable products
What is the ratio of different brands owning all nonprofitable new products
这个市场不适合进入,已经是明显的超饱和+价格战市场。 近一批新品牌几乎全军覆没:11个新品牌新上架产品里,盈利率是0%,而新产品整体盈利率也是0%;近几个月新增品牌仍在增加,但利润没有跟上,说明竞争不是在变轻,而是在继续恶化。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/11 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |